FOXO TECHNOLOGIES INC. Employee Benefits and Share-based Compensation
FOXO TECHNOLOGIES INC. (FOXO) reported Employee Benefits and Share-based Compensation of $120.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-04-15
- FOXO TECHNOLOGIES INC. employee benefits and share-based compensation for the quarter ending 2025-12-31 was $30.00K.
- FOXO TECHNOLOGIES INC. employee benefits and share-based compensation for the quarter ending 2025-09-30 was $30.00K.
- FOXO TECHNOLOGIES INC. employee benefits and share-based compensation for the quarter ending 2025-06-30 was $30.00K.
- FOXO TECHNOLOGIES INC. employee benefits and share-based compensation for the quarter ending 2025-03-31 was $30.00K.
- FOXO TECHNOLOGIES INC. employee benefits and share-based compensation for fiscal 2025 was $120.00K.
- FOXO TECHNOLOGIES INC. employee benefits and share-based compensation for fiscal 2022 was $716.00K, a 200.84% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. employee benefits and share-based compensation for fiscal 2021 was $238.00K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $60.00K derived: sum of 2 quarters · filed 2026-04-15 | $90.00K derived: sum of 3 quarters · filed 2026-04-15 | $120.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $30.00K 10-Q · filed 2025-11-10 | $60.00K derived: sum of 2 quarters · filed 2025-11-10 | $90.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $30.00K 10-Q · filed 2025-08-19 | $60.00K 10-Q · filed 2025-08-19 | ||
| 2025-03-31 | $30.00K 10-Q/A · filed 2025-08-19 | |||
| 2023-03-31 | $901.00K 10-Q · filed 2023-05-11 | $900.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.11M derived: sum of 3 quarters · filed 2023-05-11 | |
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $210.00K derived: sum of 2 quarters · filed 2023-03-31 | $716.00K 10-K · filed 2023-03-31 | |
| 2022-09-30 | $211.00K 10-Q · filed 2022-11-21 | $717.00K 10-Q · filed 2022-11-21 | ||
| 2022-03-31 | $251.00K 10-Q · filed 2023-05-11 | $387.00K derived: sum of 2 quarters · filed 2023-05-11 | $432.00K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $181.00K derived: sum of 2 quarters · filed 2023-03-31 | $238.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $45.00K 10-Q · filed 2022-11-21 | $102.00K 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |